| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.62 | 0.0002 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.63 | 0.0003 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.59 | 0.0004 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.64 | 0.0004 |